LB Pharmaceuticals Inc Common Stock (LBRX) — Analyst outlook / Analyst consensus target is. Based on 1 analyst ratings, the consensus is bullish — 1 Buy.
The consensus price target is $33.00 (low: $31.00, high: $35.00), representing an upside of 13.3% from the current price $29.12.
Analysts estimate Earnings Per Share (EPS) of $-4.03 and revenue of $0.00B for the next fiscal year.
Earnings Per Share (EPS) track record: 2025: actual $-1.00 vs est $-4.03 (beat +75.2%). Analyst accuracy: 0%.
LBRX Stock — 12-Month Price Forecast
$33.00
▲ +13.32% Upside
Average Price Target
Based on 1 Wall Street analysts offering 12-month price targets for LB Pharmaceuticals Inc Common Stock, the average price target is $33.00, with a high forecast of $35.00, and a low forecast of $31.00.
The average price target represents a +13.32% change from the last price of $29.12.
Highest Price Target
$35.00
Average Price Target
$33.00
Lowest Price Target
$31.00
LBRX Analyst Ratings
Buy
Based on 1 analysts giving stock ratings to LB Pharmaceuticals Inc Common Stock in the past 3 months
EPS Estimates — LBRX
0%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2025
Actual –$1.00
vs Est –$4.03
▲ 302.8% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
Revenue Estimates — LBRX
Revenue Trend
Analysts expect stable revenue going forward.
